Alexander Disease and the Approval of Zanvastro (Zilganersen) @checkrare
Alexander Disease and the Approval of Zanvastro (Zilganersen)  @checkrare
Uploaded September 2026 | Updated November 2026, 11 hours ago
Amy Waldman, MD, pediatric neurologist and Medical Director of the Leukodystrophy Center at the Children’s Hospital of Philadelphia, discusses the approval of zilganersen to treat patients with Alexander disease.
Alexander Disease and the Approval of Zanvastro (Zilganersen)Topline Results From the SANRECO Trial Testing Divesiran in Polycythemia VeraNew Treatment Option for Recurrent Respiratory Papillomatosis3D Printed Treatment Options | The CheckRare BriefResults From the PROGRESS Study of Zilurgisertib in Patients With FOPPhase 3 OASIS Study Shows Promise of Oral Olorofim for Invasive AspergillosisNew Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyInterim PHINDER Analyses in Interstitial Lung DiseaseCh 3: VALIANT Results on the Longer-Term Impact of EmpaveliFDA Approves New Therapies for MPS IIIA and SMA | The CheckRare Brief Ep 8Fabry Disease: Patients Real-World Problems and How to Manage ThemA Family’s Journey with Prader-Willi Syndrome
CheckRare |

Alexander Disease and the Approval of Zanvastro (Zilganersen)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER